RECRUITING

Development of CIRC Technologies

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Cardiovascular disease is the leading cause of death worldwide. Advanced cardiovascular imaging using Magnetic Resonance Imaging (MRI) has proven to be effective in providing gold standard myocardial tissue characterization. Moreover, the intrinsic advantage of MRI's lack of exposure to ionizing radiation is particularly beneficial. At the same time, blood work can be very useful in early detection of certain cardiomyopathy, such as amyloid. However, there is a lack of agreement of on which markers are the most sensitive. This multi-study will allow us the unique opportunity to form a more comprehensive understanding for various cardiovascular diseases. Our team has developed novel cardiac MRI techniques that leverages endogenous tissue properties to reveal a milieu of deep tissue phenotypes including myocardial inflammation, fibrosis, metabolism, and microstructural defects. Among these phenotypes, myocardial microstructure has proven to be most sensitive to early myocardial tissue damage and is predictive of myocardial regeneration. In this study, the investigators aim to further study the importance of cardiac microstructure revealed by MRI in patient and healthy population and compare this novel technology with conventional clinical biomarkers.

Official Title

Development of Cardiovascular Innovation Research Technologies

Quick Facts

Study Start:2022-09-09
Study Completion:2042-09-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05654272

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥ 18 years of age
  2. * Provision of written informed consent
  3. * If not healthy volunteer, must be diagnosed with cardiovascular disease
  1. * Vulnerable populations will be excluded from this study including Prisoners
  2. * Other contraindications to CMR imaging to be determined by standard MRI protocols
  3. * Decisionally impaired (e.g., dementia or cognitive disability)

Contacts and Locations

Study Contact

CIRC Program Coordinator
CONTACT
216 636-5373
circ@ccf.org
CIRC Study Coordinator
CONTACT
chens7@ccf.org

Study Locations (Sites)

Cardiovascular Innovation Research Center
Cleveland, Ohio, 44195
United States

Collaborators and Investigators

Sponsor: The Cleveland Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-09-09
Study Completion Date2042-09-09

Study Record Updates

Study Start Date2022-09-09
Study Completion Date2042-09-09

Terms related to this study

Keywords Provided by Researchers

  • MRI

Additional Relevant MeSH Terms

  • Cardiovascular Diseases
  • Heart Failure
  • Ischemic Heart Disease
  • Non-ischemic Cardiomyopathy
  • Valvular Heart Disease
  • Metabolic Cardiomyopathy
  • Congenital Heart Disease
  • Aortic Diseases
  • Atrial Fibrillation
  • Ventricular Fibrillation